Franklin Resources’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,341
Closed -$14.4K 2396
2022
Q4
$14.4K Hold
5,341
﹤0.01% 2287
2022
Q3
$21K Hold
5,341
﹤0.01% 2251
2022
Q2
$37K Sell
5,341
-2,581
-33% -$17.9K ﹤0.01% 2272
2022
Q1
$93K Hold
7,922
﹤0.01% 2307
2021
Q4
$145K Sell
7,922
-98,813
-93% -$1.81M ﹤0.01% 2288
2021
Q3
$2.67M Buy
106,735
+1,131
+1% +$28.3K ﹤0.01% 1377
2021
Q2
$6.67M Buy
105,604
+11,756
+13% +$743K ﹤0.01% 1075
2021
Q1
$11.6M Hold
93,848
﹤0.01% 945
2020
Q4
$10.7M Buy
93,848
+4
+0% +$455 ﹤0.01% 946
2020
Q3
$11.2M Hold
93,844
0.01% 879
2020
Q2
$11.7M Buy
+93,844
New +$11.7M 0.01% 834
2018
Q2
Sell
-2,778
Closed -$7.52M 1540
2018
Q1
$7.52M Buy
+2,778
New +$7.52M ﹤0.01% 977